Characteristics of Erythroleukemia Cells Selected for Vincristine Resistance That Have Accelerated Inducer-mediated Differentiation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1991 Mar 1

PMID 1672043

Citations 4

Authors

V M Richon

N Weich

L Leng

H Kiyokawa

L Ngo

R A Rifkind

P A Marks

Affiliations

Soon will be listed here.

Abstract

The induction of murine erythroleukemia cells (MELC; DS19/Sc9) to terminal differentiation by hexamethylenebisacetamide (HMBA) is characterized by a latent period of 10-12 hr before onset of commitment to terminal-cell division and increased transcription of globin genes. MELC variants, derived from this parental cell line, selected for resistance to vincristine (VC), can be induced to differentiate with little or no latent period. This study shows that accelerated HMBA-induced commitment is characteristic of MELC with a low level (2- to 5-fold) of VC resistance in four independently derived cell lines. Both resistance to VC and accelerated differentiation are stable phenotypes for at least 50 passages (approximately 5 months) in the absence of VC. Low-level VC-resistant MELC do not display increased levels of P-glycoprotein or mdr1, mdr2, and mdr3 mRNAs, nor do they exhibit cross-resistance to colchicine or doxorubicin. These cells do show (i) increased level of protein kinase C activity, (ii) reduced accumulation of [3H]VC, and (iii) restoration of VC sensitivity in the presence of verapamil. MELC selected for higher levels of VC resistance (approximately 500-fold) do express high levels of P-glycoprotein and the mdr3 gene. During HMBA-induced differentiation, DS19/Sc9 decrease [3H]VC accumulation, but P-glycoprotein content does not change. A VC-transport-associated protein, also critical for the process of induced differentiation, may be constitutively present in VC-resistant MELC, accounting for their enhanced sensitivity to inducer. This protein accumulates by exposure of VC-sensitive cells to HMBA, contributing to their differentiation and decreased level of VC accumulation.

Citing Articles

Protein kinases and multidrug resistance.

Rumsby M, Drew L, Warr J Cytotechnology. 2008; 27(1-3):203-24.

PMID: 19002793 PMC: 3449563. DOI: 10.1023/A:1008073006495.

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

Richon V, Webb Y, MERGER R, Sheppard T, Jursic B, Ngo L Proc Natl Acad Sci U S A. 1996; 93(12):5705-8.

PMID: 8650156 PMC: 39124. DOI: 10.1073/pnas.93.12.5705.

Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.

Reichle A, Diddens H, Altmayr F, Rastetter J, Andreesen R Cancer Chemother Pharmacol. 1994; 34(4):307-16.

PMID: 7913420 DOI: 10.1007/BF00686038.

Studies on low-level MDR cells.

Belvedere G, Dolfini E Cytotechnology. 1993; 12(1-3):257-64.

PMID: 7765328 DOI: 10.1007/BF00744667.

References

Juliano R, Ling V . A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976; 455(1):152-62. DOI: 10.1016/0005-2736(76)90160-7. View

Peterson R, Biedler J . Plasma membrane proteins and glycoproteins from Chinese hamster cells sensitive and resistant to actinomycin D. J Supramol Struct. 1978; 9(3):289-98. DOI: 10.1002/jss.400090302. View

Biedler J, Riehm H . Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res. 1970; 30(4):1174-84. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Melloni E, Pontremoli S, Sparatore B, Patrone M, Grossi F, Marks P . Introduction of the beta isozyme of protein kinase C accelerates induced differentiation of murine erythroleukemia cells. Proc Natl Acad Sci U S A. 1990; 87(12):4417-20. PMC: 54125. DOI: 10.1073/pnas.87.12.4417. View

Lachman H, SKOULTCHI A . Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature. 1984; 310(5978):592-4. DOI: 10.1038/310592a0. View

Burnette W . "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981; 112(2):195-203. DOI: 10.1016/0003-2697(81)90281-5. View

Shen D, Real F, DeLeo A, Old L, Marks P, Rifkind R . Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proc Natl Acad Sci U S A. 1983; 80(19):5919-22. PMC: 390188. DOI: 10.1073/pnas.80.19.5919. View

Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y . Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 1981; 41(5):1967-72. View

10.

Gusella J, Geller R, Clarke B, Weeks V, Housman D . Commitment to erythroid differentiation by friend erythroleukemia cells: a stochastic analysis. Cell. 1976; 9(2):221-9. DOI: 10.1016/0092-8674(76)90113-6. View

11.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

12.

Posada J, McKeegan E, Worthington K, MORIN M, Jaken S, Tritton T . Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Commun. 1989; 1(5):285-92. DOI: 10.3727/095535489820874922. View

13.

Fine R, Patel J, Chabner B . Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci U S A. 1988; 85(2):582-6. PMC: 279595. DOI: 10.1073/pnas.85.2.582. View

14.

Gros P, Raymond M, Bell J, Housman D . Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol. 1988; 8(7):2770-8. PMC: 363494. DOI: 10.1128/mcb.8.7.2770-2778.1988. View

15.

Melloni E, Pontremoli S, Damiani G, Viotti P, Weich N, Rifkind R . Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation. Proc Natl Acad Sci U S A. 1988; 85(11):3835-9. PMC: 280314. DOI: 10.1073/pnas.85.11.3835. View

16.

Gros P, Ben Neriah Y, Croop J, Housman D . Isolation and expression of a complementary DNA that confers multidrug resistance. Nature. 1986; 323(6090):728-31. DOI: 10.1038/323728a0. View

17.

Ramsay R, Ikeda K, Rifkind R, Marks P . Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division. Proc Natl Acad Sci U S A. 1986; 83(18):6849-53. PMC: 386607. DOI: 10.1073/pnas.83.18.6849. View

18.

Todokoro K, Ikawa Y . Sequential expression of proto-oncogenes during a mouse erythroleukemia cell differentiation. Biochem Biophys Res Commun. 1986; 135(3):1112-8. DOI: 10.1016/0006-291x(86)91043-0. View

19.

Aquino A, Hartman K, Knode M, Grant S, Huang K, Niu C . Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Res. 1988; 48(12):3324-9. View

20.

Endicott J, Ling V . The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem. 1989; 58:137-71. DOI: 10.1146/annurev.bi.58.070189.001033. View